GABA,-aminobutyric acid
Jimena Hathaway, MD, MPH, published in the Journal of the American Medical Association, indicates that Semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus, shows an increased risk of vision loss
This allows your body to adjust to the change in dosage while also giving yourself longer to form and solidify your new diet and exercise habits, which will be critical in maintaining your weight loss long-term
Even while taking GLP-1 medication, these hormones continue to influence appetite
The five-day half-life also explains why split dosing (dividing the weekly amount into two or three administrations) can smooth out the experience
Understanding these aspects is critical for health care providers, payers and patients looking to balance health outcomes, affordability, and innovation